EVOFEM BIOSCIENCES, INC. Accumulated Other Comprehensive Income
EVOFEM BIOSCIENCES, INC. (EVFM) had Accumulated Other Comprehensive Income of -$5.38 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.38M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$6.64M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$8.82M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$6.72M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$5.38M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$6.64M 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$8.82M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$6.72M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$2.56M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$1.98M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$2.63M 10-K · filed 2026-03-11 |
| 2024-09-30 | -$1.71M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$781.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$525.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$849.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$287.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $73.36M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $64.99M 10-Q · filed 2023-06-16 |
| 2022-12-31 | $49.53M 10-K · filed 2024-03-27 |
| 2022-09-30 | $36.96M 10-Q · filed 2023-01-06 |
| 2022-06-30 | $1.59M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $5.27M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $5.09M 10-K · filed 2023-04-27 |
| 2021-09-30 | $5.09M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 |